Atrioventricular junctional ablation: The good, the bad, the better

Background: The management of patients with atrial fibrillation and an abnormally fast ventricular response has been through the use of pharmacologic agents. In those cases where rate control cannot be achieved pharmacologically, a standard approach has been atrioventricular (AV) junctional ablation...

Full description

Bibliographic Details
Main Authors: Benjamin J. Scherlag, PhD, FHRS, Khaled Elkholey, MD, Stavros Stavrakis, MD, PhD, Warren M. Jackman, MD, FHRS, Sunny S. Po, MD, PhD, FHRS
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Heart Rhythm O2
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666501820300763